Alira Health’s Transformation Talks: Real-World Evidence Strategy Playbook

Medical and healthcare data have been gathered through various channels over the last twenty years, and with recent innovations, it offers new opportunities, becoming a crucial factor in market access strategies and clinical research. In this episode of Alira Health‘s Transformation Talks, our host Kenny Carberry, Director of Clinical Development at Alira Health, and Romain Finas, Vice President of Real-World Evidence at Alira Health, will discuss how industry stakeholders can leverage RWD to be more efficient, cost-effective, and thus increase their benefits without compromising quality.

Listen to this podcast to discover how industry stakeholders may use RWD to be more efficient, cost-effective, and maximize their benefits without sacrificing data quality and why the role of patients as an essential aspect of data gathering and sourcing cannot be overlooked when considering RWE.

Meet our speakers:

Romain Finas – Vice President, Real-World Evidence, Alira Health

Romain Finas has been building the Real-World Evidence practice for AliraHealth since mid-2020. Before AliraHealth, Romain designed and implemented the“beyond the pill” strategy for MSD France. He started living labs to test and assess innovations based on real-time data routinely collected by practitioners, among other initiatives. Romain has 20 years of experience in consultancy, healthcare, and digital.

Meet our host:

Kenny Carberry – Director, Clinical Development, Alira Health

Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers various indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle, from generating a comprehensive strategy to executing a successful trial.